iHuman is an education & training services business based in the US. iHuman shares (IH) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $1.52 – a decrease of 7.15% over the previous week. iHuman employs 783 staff and has a trailing 12-month revenue of around $962.1 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.52 |
|---|---|
| 52-week range | $1.47 - $3.00 |
| 50-day moving average | $1.81 |
| 200-day moving average | $1.82 |
| Wall St. target price | $3.86 |
| PE ratio | N/A |
| Dividend yield | $0 (5.52%) |
| Earnings per share (TTM) | $-0.16 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.52 from 2024-11-22
| 1 week (2024-11-18) | -6.75% |
|---|---|
| 1 month (2024-10-25) | -15.56% |
| 3 months (2024-08-23) | -6.17% |
| 6 months (2024-05-24) | -24.75% |
| 1 year (2023-11-24) | -40.39% |
|---|---|
| 2 years (2022-11-23) | -23.02% |
| 3 years (2021-11-24) | 4.4214 |
| 5 years (2019-11-21) | N/A |
Valuing iHuman stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iHuman's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iHuman's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $110.7 million.
The EBITDA is a measure of a iHuman's overall financial performance and is widely used to measure a its profitability.
To put iHuman's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $962.1 million |
|---|---|
| Operating margin TTM | 8.75% |
| Gross profit TTM | $660.6 million |
| Return on assets TTM | 4.56% |
| Return on equity TTM | 14.79% |
| Profit margin | 13.74% |
| Book value | $17.36 |
| Market Capitalization | $81.1 million |
TTM: trailing 12 months
Dividend payout ratio: 49.14% of net profits
Recently iHuman has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), iHuman shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In iHuman's case, that would currently equate to about $0 per share.
While iHuman's payout ratio might seem fairly standard, it's worth remembering that iHuman may be investing much of the rest of its net profits in future growth.
iHuman's most recent dividend payout was on 14 May 2024. The latest dividend was paid out to all shareholders who bought their shares by 26 March 2024 (the "ex-dividend date").
iHuman's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Over the last 12 months, iHuman's shares have ranged in value from as little as $1.47 up to $3.0043. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while iHuman's is 0.468. This would suggest that iHuman's shares are less volatile than average (for this exchange).
To put iHuman's beta into context you can compare it against those of similar companies.
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery. It provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.